The 7 Major Carotid Artery Disease Markets Poised for 3.03% CAGR Growth During 2024-2034
According to the IMARC Group, the carotid artery disease market is projected at a CAGR of 3.03% during 2024-2034. This can be attributed to the continuous developments in endovascular techniques, like the introduction of transcarotid artery revascularization as well as transradial carotid artery stenting, which are less invasive with less likelihood of side effects.
Carotid artery disease, or carotid artery stenosis, develops when the carotid arteries, which carry oxygenated blood to the brain, become narrowed or become blocked. The carotid artery disease market is expanding rapidly, owing to the rising incidences of cardiovascular diseases, which are linked to aging populations and unhealthy lifestyles. Additionally, advancements in medical imaging and diagnostic technologies have significantly improved early detection, thereby fueling the demand for effective treatment options. Furthermore, the growing adoption of less invasive procedures, such as carotid artery stenting, is contributing to market expansion due to their shorter recovery times and lesser risk of complications compared to traditional surgery.
In line with these factors, the integration of artificial intelligence in diagnostic imaging is enhancing the accuracy and efficiency of carotid artery disease detection, thereby boosting the growth of the carotid artery disease market. Moreover, the market is also witnessing a surge in research and development activities focused on innovative drug therapies and bioresorbable stents, which promise improved patient outcomes. Consequently, the growing preference for outpatient care and ambulatory surgical centers is reshaping the therapeutic landscape by offering cost-effective alternatives to hospital-based procedures. The increasing emphasis on precision medicine, which tailors treatment to individual patient profiles, is also anticipated to drive the carotid artery disease market growth in the coming years.
Request for a sample of this report: https://www.imarcgroup.com/carotid-artery-disease-market/requestsample
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the carotid artery disease market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the carotid artery disease market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current carotid artery disease market drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape with key players:
The competitive landscape of the carotid artery disease market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these Key Players:
- AFYX Therapeutics
- Incyte Corporation
- Novartis
Ask Analyst for Customization and Explore Full Report with TOC: https://www.imarcgroup.com/carotid-artery-disease-market/toc
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145